BBP250117P59000
- 0.00
- 0.000.00%
Virtus Lifesci Biotech Products Etf Newsroom
Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Moderna Analyst Ratings
Neurocrine Biosciences Analyst Ratings
Halozyme Therapeutics Shares Are Trading Higher After the Company Reported Preliminary Financial Results and Raised Its FY25 Guidance.
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies
Stocks Sink As Bond Yields Soar, Nvidia Eyes Worst Day In 4 Months, Bitcoin Tumbles To $97,000: What's Driving Markets Tuesday?
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally
Moderna, Novavax and Other Vaccine Names Extend Gains Amid COVID/flu Concerns
Benzinga Market Summary: Bitcoin Falls, Vaccine Stocks Rise On Bird Flu Concerns, NVIDIA Drops
Why Novavax (NVAX) Stock Is Rising
Shares of Vaccine Makers Are Trading Higher After the First Bird Flu Death Was Reporting in the US. Additionally, a Recent DCD Report Noted an Increase in Acute Respiratory Illness Activity.
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Spotlight on Moderna: Analyzing the Surge in Options Activity
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Bird Flu Claims First U.S. Life in Louisiana
'LDH Reports First U.S. H5N1-Related Human Death' - Louisiana Department Of Health
Why Moderna (MRNA) Stock Is Trading Higher
Moderna CEO Letter Says With A Full Season Of RSV Contracting In 2025, Expect To Increase MRESVIA's Market Share In U.S. And Market Access Globally; Plan To Bring Manufacturing Plants Online In The UK, Canada And Australia In 2025